已发表论文

新型炎症指标在原发性胆汁性胆管炎患者熊去氧胆酸治疗反应中的应用价值

 

Authors Liu S , Pang Y, Wang X, Lin R , Tunala S

Received 26 August 2024

Accepted for publication 30 January 2025

Published 19 February 2025 Volume 2025:18 Pages 897—905

DOI https://doi.org/10.2147/IJGM.S493132

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Hossam E-Din Shaaban

Siqi Liu,1 Yongli Pang,2 Xiaoxi Wang,3 Ruihang Lin,4 Siqing Tunala5 

1Inner Mongolia Medical University, Hohhot, Inner Mongoli, People’s Republic of China; 2Ordos second People’s Hospital, Ordos, Inner Mongoli, People’s Republic of China; 3People’s Hospital of Ordos Dongsheng District, Ordos, Inner Mongoli, People’s Republic of China; 4Ordos Central Hospital, Ordos, Inner Mongoli, People’s Republic of China; 5Ordos Mongolian Medicine Hospital, Ordos, Inner Mongoli, People’s Republic of China

Correspondence: Siqing Tunala, Ordos Mongolian Medicine Hospital, Ordos, Inner Mongoli, People’s Republic of China, Email tutu88600@126.com

Objective: To analyze the application value of novel inflammation indicators such as the lymphocyte/monocyte ratio (LMR), neutrophil/lymphocyte ratio (NLR), and platelet/lymphocyte ratio (PLR) in patients with primary biliary cholangitis (PBC) undergoing ursodeoxycholic acid (UDCA) treatment. We plan to further seek simple and convenient methods to assess the response of patients to UDCA treatment.
Methods: We recorded routine blood tests, liver function, and vitamin D (VD) levels of PBC patients and healthy controls visiting the hospital between October 2022 and October 2023. LMR, NLR, and PLR were calculated, and differences between the two groups were analyzed. PBC patients were divided into good response and poor response groups according to the Paris I criteria, and differences in laboratory tests between the two groups were analyzed. The predictive value of novel inflammation indicators in UDCA treatment response was further analyzed using ROC analysis.
Results: LMR and VD levels were significantly lower in the PBC group compared to the control group (P=0.000, P=0.000). In PBC patients, the good response group had higher LMR than the poor response group (P=0.001) and lower NLR than the poor response group (P=0.015). The areas under the ROC curve for LMR and NLR were 0.682± 0.049 and 0.630± 0.052, respectively. There was a significant negative correlation between PLR and VD in PBC patients (r=− 0.252, P=0.005).
Conclusion: Low LMR and high NLR may indicate poor treatment response. And PLR also have certain predictive values for treatment response.

Keywords: primary biliary cholangitis, lymphocyte/monocyte ratio, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, vitamin D